Skip to main content
SpringerLink
Log in

Noninvasive Screening and Testing for PAD in CKD Patients

  • Chapter
  • First Online:
Interventional Nephrology

  • 1305 Accesses

Abstract

Peripheral arterial disease (PAD) is a cardiovascular disease risk equivalent and is a common problem in chronic kidney disease patients. In addition to the process of intimal atherosclerosis that is associated with traditional risk factors such as diabetes and tobacco abuse, PAD in CKD occurs due to medical calcification. PAD intervention should be performed in select symptomatic patients, as described by the guidelines, and CVD risk factor modification should occur in all CKD patients, regardless of the presence of PAD. The purpose of this chapter is to describe the screening and testing for PAD in CKD and ESRD patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. USRDS: United States Renal Data System Annual Data Report, Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Division of Kidney Urologic and Hematologic Diseases. 2000. p. 339–48.

    Google Scholar 

  2. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489–95.

    Article  PubMed  Google Scholar 

  3. Murabito JM, Evans JC, Larson MG, et al. The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham study. Arch Intern Med. 2003;163(16):1939–42.

    Article  PubMed  Google Scholar 

  4. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the cardiovascular health study: the cardiovascular health study group. Arterioscler Thromb Vasc Biol. 1999;19(3):538–45.

    Article  PubMed  CAS  Google Scholar 

  5. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326(6):381–6.

    Article  PubMed  CAS  Google Scholar 

  6. Kerr PG, Guérin AP. Arterial calcification and stiffness in chronic kidney disease. Clin Exp Pharmacol Physiol. 2007;34(7):683–7.

    Article  PubMed  CAS  Google Scholar 

  7. Robinson RF, Nahata MC, Sparks E, et al. Abnormal left ventricular mass and aortic distensibility in pediatric dialysis patients. Pediatr Nephrol. 2005;20(1):64–8.

    Article  PubMed  Google Scholar 

  8. Goodman WG, Goldin J, Kuizon BD, et al. Coronary artery calcification in young adults with end-stage renal disease who are undergoing hemodialysis. N Engl J Med. 2000;342(20):1478–83.

    Article  PubMed  CAS  Google Scholar 

  9. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15:2208–18.

    Article  PubMed  CAS  Google Scholar 

  10. Young EW, Akiba T, Albert JM, et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis. 2004;44(5 Suppl 2):34–8.

    Article  PubMed  Google Scholar 

  11. Cooper BA, Penne EL, Bartlett LH, Pollack CA. Protein malnutrition and hypoalbuminemia as predictors of vascular events and mortality in ESRD. Am J Kidney Dis. 2004;43(1):61–6.

    Article  PubMed  Google Scholar 

  12. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344(21):1608–21.

    Article  PubMed  CAS  Google Scholar 

  13. Braunwald E, Zipes DP, Libby P. Heart disease: a textbook of cardiovascular medicine. Philadelphia: Saunders; 2001.

    Google Scholar 

  14. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286(11):1317–24.

    Article  PubMed  CAS  Google Scholar 

  15. Hirsch AT, Hiatt WR, PARTNERS Steering Committee. PAD awareness, risk, and treatment: new resources for survival–the USA PARTNERS program. Vasc Med. 2001;6(3 Suppl):9–12.

    Article  PubMed  CAS  Google Scholar 

  16. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999–2000. Circulation. 2004;110(6):738–43.

    Article  PubMed  Google Scholar 

  17. Lamar Welch VL, Casper M, Greenlund K, Zheng ZJ, Giles W, Rith-Najarian S. Prevalence of lower extremity arterial disease defined by the ankle-brachial index among American Indians: the Inter-Tribal Heart Project. Ethn Dis. 2002;12:S1-63-S7.

    Google Scholar 

  18. Leskinen Y, Salenius JP, Lehtimäki T, Huhtala H, Saha H. The prevalence of peripheral arterial disease and medial arterial calcification in patients with chronic renal failure: requirements for diagnostics. Am J Kidney Dis. 2002;40(3):472–9.

    Article  PubMed  Google Scholar 

  19. Newman AB, Siscovick DS, Manolio TA, et al. Ankle-arm index as a marker of atherosclerosis in the cardiovascular health study: cardiovascular heart study (CHS) collaborative research group. Circulation. 1993;88(3):837–45.

    Article  PubMed  CAS  Google Scholar 

  20. Eggers PW, Gohdes D, Pugh J. Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. Kidney Int. 1999;56:1524–33.

    Article  PubMed  CAS  Google Scholar 

  21. DeLoach SS, Mohler 3rd ER. Peripheral arterial disease: a guide for nephrologists. Clin J Am Soc Nephrol. 2007;2(4):839–46.

    Article  PubMed  Google Scholar 

  22. O’Hare AM, Glidden DV, Fox CS, Hsu CY. High prevalence of peripheral arterial disease in persons with renal insufficiency. Circulation. 2004;109(3):320–3.

    Article  PubMed  Google Scholar 

  23. O’Hare AM, Hsu CY, Bacchetti P, Johansen KL. Peripheral vascular disease risk factors among patients undergoing hemodialysis. J Am Soc Nephrol. 2002;13(2):497–503.

    PubMed  Google Scholar 

  24. Mcdermott MM, Greenland P, Liu K, et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001;286(13):1599–606.

    Article  PubMed  CAS  Google Scholar 

  25. McGee SR, Boyko EJ. Physical examination and chronic lower-extremity ischemia: a critical review. Arch Intern Med. 1998;158(12):1357–64.

    Article  PubMed  CAS  Google Scholar 

  26. McDermott MM, Criqui MH, Liu K, et al. Lower ankle/brachial index, as calculated by averaging the dorsalis pedis and posterior tibial arterial pressures, and association with leg functioning in peripheral arterial disease. J Vasc Surg. 2000;32(6):1164–71.

    Article  PubMed  CAS  Google Scholar 

  27. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1–75.

    Article  PubMed  Google Scholar 

  28. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45(4 Supple 3):S1–153.

    Google Scholar 

  29. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26(3):517–38.

    Article  PubMed  CAS  Google Scholar 

  30. Heald CL, Fowkes FG, Murray GD, Price JF. Ankle brachial index collaboration: risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189(1):61–9.

    Article  PubMed  CAS  Google Scholar 

  31. Steffen LM, Duprez DA, Boucher JL, Ershow AG, Hirsch AT. Management of peripheral arterial disease. Diabetes Spectrum. 2008;21(3):171.

    Article  Google Scholar 

  32. McLafferty RB, Moneta GL, Taylor Jr LM, Porter JM. Ability of ankle-brachial index to detect lower-extremity atherosclerotic disease progression. Arch Surg. 1997;132(8):836–40.

    Article  PubMed  CAS  Google Scholar 

  33. Okamoto K, Oka M, Maesato K, et al. Peripheral arterial occlusive disease is more prevalent in patients with hemodialysis: comparison with the findings of multidetector-row computed tomography. Am J Kidney Dis. 2006;48(2):269–76.

    Article  PubMed  Google Scholar 

  34. Ogata H, Kumata-Maeta C, Shishido K, et al. Detection of peripheral artery disease by duplex ultrasonography among hemodialysis patients. Clin J Am Soc Nephrol. 2010;5(12):2199–206.

    Article  PubMed  Google Scholar 

  35. Haemel AK, Sadowski EA, Shafer MM, Djamali A. Update on nephrogenic systemic fibrosis: are we making progress? Int J Dermatol. 2011;50(6):659–66.

    Article  PubMed  Google Scholar 

  36. Li JH, He NS. Prevention of iodinated contrast-induced nephropathy. Chin Med J (Engl). 2011;124(23):4079–82.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Department of Medicine (CHS), University of Wisconsin, Madison, WI, 53705, USA

    Alexander S. Yevzlin MD

  2. Division of Cardiovascular Medicine, Department of Medicine, University of Wisconsin College of Medicine and Public Health, Madison, WI, USA

    Peter J. Mason

Authors
  1. Alexander S. Yevzlin MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter J. Mason
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander S. Yevzlin MD .

Editor information

Editors and Affiliations

  1. Department of Medicine (CHS), Division of Nephrology, Madison, Wisconsin, USA

    Alexander S. Yevzlin

  2. Medicine, Nephrology and Hypertension, Albany Medical College, Albany, New York, USA

    Arif Asif

  3. Interventional Nephrology Nephrology and Hypertension, University of Miami Miller School of Med, Miami, Florida, USA

    Loay Salman

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Yevzlin, A.S., Mason, P.J. (2014). Noninvasive Screening and Testing for PAD in CKD Patients. In: Yevzlin, A., Asif, A., Salman, L. (eds) Interventional Nephrology. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8803-3_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8803-3_6

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-8802-6

  • Online ISBN: 978-1-4614-8803-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation